Literature DB >> 19689746

Estimation of Iranian stroke patients eligible for intravenous thrombolysis with tPA.

K Ghandehari, A Pour Zahed, M Taheri, M Abbasi, S Gorjestani, A Moghaddam Ahmadi, M A Nahayati.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19689746     DOI： 10.1111/j.1747-4949.2009.00273.x

Source DB:  PubMed          Journal:  Int J Stroke        ISSN： 1747-4930            Impact factor:   5.266


× No keyword cloud information.
  10 in total

1.  Stroke in patients with diabetes mellitus: a study from North Western Nigeria.

Authors:  Lukman Owolabi; Mansur Nagode; Aliyu Ibrahim; Andrew Uloko; Ibrahim Gezawa; Mohammad Datti
Journal:  Afr Health Sci       Date:  2016-09       Impact factor: 0.927

2.  Barriers of thrombolysis therapy in developing countries.

Authors:  Kavian Ghandehari
Journal:  Stroke Res Treat       Date:  2011-03-17

3.  Design of a standard Iranian protocol of Intravenous thrombolysis with tissue plasminogen activator: A national project.

Authors:  Kavian Ghandehari
Journal:  Iran J Neurol       Date:  2013

4.  Factors associated with death and predictors of one-month mortality from stroke in Kano, Northwestern Nigeria.

Authors:  Owolabi Lukman Femi; Nagoda Mansur
Journal:  J Neurosci Rural Pract       Date:  2013-08

5.  Intravenous recombinant tissue plasminogen activator for acute ischemic stroke: a feasibility and safety study.

Authors:  Elyar Sadeghi-Hokmabadi; Mehdi Farhoudi; Aliakbar Taheraghdam; Mazyar Hashemilar; Daryous Savadi-Osguei; Reza Rikhtegar; Kaveh Mehrvar; Ehsan Sharifipour; Parisa Youhanaee; Reshad Mirnour
Journal:  Int J Gen Med       Date:  2016-10-25

6.  Assessment of neurologists' knowledge regarding intravenous fibrinolytic therapy for acute stroke in Shanxi province in China.

Authors:  Liansheng Ma; Xiaoyuan Niu; Wei Zhang; Yalan Fang; Jie Wang
Journal:  BMC Health Serv Res       Date:  2017-05-18       Impact factor: 2.655

Review 7.  A systematic review of the cost-effectiveness of emergency interventions for stroke in low- and middle-income countries.

Authors:  Euridxe Barbosa; Brito Gulela; Maria A Taimo; Dino M Lopes; O Agatha Offorjebe; Nicholas Risko
Journal:  Afr J Emerg Med       Date:  2020-06-11

8.  Eligibility assessment for intravenous thrombolytic therapy in acute ischemic stroke patients; evaluating barriers for implementation.

Authors:  Hormoz Ayromlou; Hassan Soleimanpour; Mehdi Farhoudi; Aliakbar Taheraghdam; Elyar Sadeghi Hokmabadi; Rouzbeh Rajaei Ghafouri; Mehdi Najafi Nashali; Ehsan Sharifipour; Somayeh Mostafaei; Davar Altafi
Journal:  Iran Red Crescent Med J       Date:  2014-05-05       Impact factor: 0.611

9.  Low-Dose Versus Standard-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke in Asian Populations: A Meta-Analysis.

Authors:  Meng-Dong Liu; Wei-Dong Ning; Ren-Cong Wang; Wei Chen; Yang Yang; Yan Lin; Da-Hai Hu; Wayne-Bond Lau; Yan Qu
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

10.  Acute management of stroke in Iran: Obstacles and solutions.

Authors:  Shima Shahjouei; Reza Bavarsad-Shahripour; Farhad Assarzadegan; Reza Rikhtegar; Masoud Mehrpour; Babak Zamani; Georgios Tsivgoulis; Andrei Alexandrov; Anne Alexandrov; Ramin Zand
Journal:  Iran J Neurol       Date:  2017-04-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.